1h Free Analyst Time
The global cell therapy market is forecasted to grow by USD 18.16 billion during 2025-2030, accelerating at a CAGR of 21.9% during the forecast period. The report on the global cell therapy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic and degenerative diseases, technological advancements and innovations in cell engineering, expanding clinical pipeline and strategic industry collaborations.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The global cell therapy market is segmented as below:
By Type
- Autologous
- Allogenic
By Application
- Malignancies
- Musculoskeletal
- Cardiovascular
- Others
By End-User
- Biopharmaceutical companies
- CMOs
- CROs
- Academic and research institutes
By Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (RoW)
- Rest of World (RoW)
The report on the global cell therapy market covers the following areas:
- Global cell therapy market sizing
- Global cell therapy market forecast
- Global cell therapy market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Chart on Overview on criticality of inputs and factors of differentiation
- Chart on Overview on factors of disruption
- Chart on Impact of drivers and challenges in 2025 and 2030
3 Market Landscape
3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- Chart on Market characteristics analysis
- Chart on Value chain analysis
4 Market Sizing
4.1 Market definition
4.4 Market outlook: Forecast for 2025-2030
- Data Table on Offerings of companies included in the market definition
- Market segments
4.4 Market outlook: Forecast for 2025-2030
- Chart on Global - Market size and forecast 2025-2030 ($ million)
- Data Table on Global - Market size and forecast 2025-2030 ($ million)
- Chart on Global Market: Year-over-year growth 2025-2030 (%)
- Data Table on Global Market: Year-over-year growth 2025-2030 (%)
5 Historic Market Size
5.1 Global Cell Therapy Market 2020 - 2024
- Historic Market Size - Data Table on Global Cell Therapy Market 2020 - 2024 ($ million)
- Historic Market Size - Type Segment 2020 - 2024 ($ million)
- Historic Market Size - Application Segment 2020 - 2024 ($ million)
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
6.1 Impact of AI on global cell therapy market
6.2 Impact of geopolitical conflicts on global cell therapy market
6.2 Impact of geopolitical conflicts on global cell therapy market
7 Five Forces Analysis
7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- Threat of new entrants - Impact of key factors in 2025 and 2030
- Threat of substitutes - Impact of key factors in 2025 and 2030
- Threat of rivalry - Impact of key factors in 2025 and 2030
- Chart on Market condition - Five forces 2025 and 2030
8 Market Segmentation by Type
8.1 Market segments
- Chart on Type - Market share 2025-2030 (%)
- Data Table on Type - Market share 2025-2030 (%)
- Chart on Comparison by Type
- Data Table on Comparison by Type
- Chart on Autologous - Market size and forecast 2025-2030 ($ million)
- Data Table on Autologous - Market size and forecast 2025-2030 ($ million)
- Chart on Autologous - Year-over-year growth 2025-2030 (%)
- Data Table on Autologous - Year-over-year growth 2025-2030 (%)
- Chart on Allogenic - Market size and forecast 2025-2030 ($ million)
- Data Table on Allogenic - Market size and forecast 2025-2030 ($ million)
- Chart on Allogenic - Year-over-year growth 2025-2030 (%)
- Data Table on Allogenic - Year-over-year growth 2025-2030 (%)
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)
9 Market Segmentation by Application
9.1 Market segments
- Chart on Application - Market share 2025-2030 (%)
- Data Table on Application - Market share 2025-2030 (%)
- Chart on Comparison by Application
- Data Table on Comparison by Application
- Chart on Malignancies - Market size and forecast 2025-2030 ($ million)
- Data Table on Malignancies - Market size and forecast 2025-2030 ($ million)
- Chart on Malignancies - Year-over-year growth 2025-2030 (%)
- Data Table on Malignancies - Year-over-year growth 2025-2030 (%)
- Chart on Musculoskeletal - Market size and forecast 2025-2030 ($ million)
- Data Table on Musculoskeletal - Market size and forecast 2025-2030 ($ million)
- Chart on Musculoskeletal - Year-over-year growth 2025-2030 (%)
- Data Table on Musculoskeletal - Year-over-year growth 2025-2030 (%)
- Chart on Cardiovascular - Market size and forecast 2025-2030 ($ million)
- Data Table on Cardiovascular - Market size and forecast 2025-2030 ($ million)
- Chart on Cardiovascular - Year-over-year growth 2025-2030 (%)
- Data Table on Cardiovascular - Year-over-year growth 2025-2030 (%)
- Chart on Others - Market size and forecast 2025-2030 ($ million)
- Data Table on Others - Market size and forecast 2025-2030 ($ million)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
- Market opportunity by Application ($ million)
- Data Table on Market opportunity by Application ($ million)
10 Market Segmentation by End-user
10.1 Market segments
- Chart on End-user - Market share 2025-2030 (%)
- Data Table on End-user - Market share 2025-2030 (%)
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
- Chart on Biopharmaceutical companies - Market size and forecast 2025-2030 ($ million)
- Data Table on Biopharmaceutical companies - Market size and forecast 2025-2030 ($ million)
- Chart on Biopharmaceutical companies - Year-over-year growth 2025-2030 (%)
- Data Table on Biopharmaceutical companies - Year-over-year growth 2025-2030 (%)
- Chart on CMOs - Market size and forecast 2025-2030 ($ million)
- Data Table on CMOs - Market size and forecast 2025-2030 ($ million)
- Chart on CMOs - Year-over-year growth 2025-2030 (%)
- Data Table on CMOs - Year-over-year growth 2025-2030 (%)
- Chart on CROs - Market size and forecast 2025-2030 ($ million)
- Data Table on CROs - Market size and forecast 2025-2030 ($ million)
- Chart on CROs - Year-over-year growth 2025-2030 (%)
- Data Table on CROs - Year-over-year growth 2025-2030 (%)
- Chart on Academic and research institutes - Market size and forecast 2025-2030 ($ million)
- Data Table on Academic and research institutes - Market size and forecast 2025-2030 ($ million)
- Chart on Academic and research institutes - Year-over-year growth 2025-2030 (%)
- Data Table on Academic and research institutes - Year-over-year growth 2025-2030 (%)
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)
11 Customer Landscape
11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
- Chart on Market share by geography 2025-2030 (%)
- Data Table on Market share by geography 2025-2030 (%)
- Chart on Geographic comparison
- Data Table on Geographic comparison
- Chart on North America - Market size and forecast 2025-2030 ($ million)
- Data Table on North America - Market size and forecast 2025-2030 ($ million)
- Chart on North America - Year-over-year growth 2025-2030 (%)
- Data Table on North America - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- Chart on US - Market size and forecast 2025-2030 ($ million)
- Data Table on US - Market size and forecast 2025-2030 ($ million)
- Chart on US - Year-over-year growth 2025-2030 (%)
- Data Table on US - Year-over-year growth 2025-2030 (%)
- Chart on Canada - Market size and forecast 2025-2030 ($ million)
- Data Table on Canada - Market size and forecast 2025-2030 ($ million)
- Chart on Canada - Year-over-year growth 2025-2030 (%)
- Data Table on Canada - Year-over-year growth 2025-2030 (%)
- Chart on Mexico - Market size and forecast 2025-2030 ($ million)
- Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
- Chart on Mexico - Year-over-year growth 2025-2030 (%)
- Data Table on Mexico - Year-over-year growth 2025-2030 (%)
- Chart on Europe - Market size and forecast 2025-2030 ($ million)
- Data Table on Europe - Market size and forecast 2025-2030 ($ million)
- Chart on Europe - Year-over-year growth 2025-2030 (%)
- Data Table on Europe - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- Chart on Germany - Market size and forecast 2025-2030 ($ million)
- Data Table on Germany - Market size and forecast 2025-2030 ($ million)
- Chart on Germany - Year-over-year growth 2025-2030 (%)
- Data Table on Germany - Year-over-year growth 2025-2030 (%)
- Chart on UK - Market size and forecast 2025-2030 ($ million)
- Data Table on UK - Market size and forecast 2025-2030 ($ million)
- Chart on UK - Year-over-year growth 2025-2030 (%)
- Data Table on UK - Year-over-year growth 2025-2030 (%)
- Chart on France - Market size and forecast 2025-2030 ($ million)
- Data Table on France - Market size and forecast 2025-2030 ($ million)
- Chart on France - Year-over-year growth 2025-2030 (%)
- Data Table on France - Year-over-year growth 2025-2030 (%)
- Chart on Italy - Market size and forecast 2025-2030 ($ million)
- Data Table on Italy - Market size and forecast 2025-2030 ($ million)
- Chart on Italy - Year-over-year growth 2025-2030 (%)
- Data Table on Italy - Year-over-year growth 2025-2030 (%)
- Chart on Spain - Market size and forecast 2025-2030 ($ million)
- Data Table on Spain - Market size and forecast 2025-2030 ($ million)
- Chart on Spain - Year-over-year growth 2025-2030 (%)
- Data Table on Spain - Year-over-year growth 2025-2030 (%)
- Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
- Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
- Chart on Asia - Market size and forecast 2025-2030 ($ million)
- Data Table on Asia - Market size and forecast 2025-2030 ($ million)
- Chart on Asia - Year-over-year growth 2025-2030 (%)
- Data Table on Asia - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- Chart on China - Market size and forecast 2025-2030 ($ million)
- Data Table on China - Market size and forecast 2025-2030 ($ million)
- Chart on China - Year-over-year growth 2025-2030 (%)
- Data Table on China - Year-over-year growth 2025-2030 (%)
- Chart on India - Market size and forecast 2025-2030 ($ million)
- Data Table on India - Market size and forecast 2025-2030 ($ million)
- Chart on India - Year-over-year growth 2025-2030 (%)
- Data Table on India - Year-over-year growth 2025-2030 (%)
- Chart on Japan - Market size and forecast 2025-2030 ($ million)
- Data Table on Japan - Market size and forecast 2025-2030 ($ million)
- Chart on Japan - Year-over-year growth 2025-2030 (%)
- Data Table on Japan - Year-over-year growth 2025-2030 (%)
- Chart on South Korea - Market size and forecast 2025-2030 ($ million)
- Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
- Chart on South Korea - Year-over-year growth 2025-2030 (%)
- Data Table on South Korea - Year-over-year growth 2025-2030 (%)
- Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
- Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
- Chart on Indonesia - Year-over-year growth 2025-2030 (%)
- Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
- Chart on Thailand - Market size and forecast 2025-2030 ($ million)
- Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
- Chart on Thailand - Year-over-year growth 2025-2030 (%)
- Data Table on Thailand - Year-over-year growth 2025-2030 (%)
- Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- Chart on Brazil - Market size and forecast 2025-2030 ($ million)
- Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
- Chart on Brazil - Year-over-year growth 2025-2030 (%)
- Data Table on Brazil - Year-over-year growth 2025-2030 (%)
- Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Chart on UAE - Market size and forecast 2025-2030 ($ million)
- Data Table on UAE - Market size and forecast 2025-2030 ($ million)
- Chart on UAE - Year-over-year growth 2025-2030 (%)
- Data Table on UAE - Year-over-year growth 2025-2030 (%)
- Chart on Turkey - Market size and forecast 2025-2030 ($ million)
- Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
- Chart on Turkey - Year-over-year growth 2025-2030 (%)
- Data Table on Turkey - Year-over-year growth 2025-2030 (%)
- Chart on Argentina - Market size and forecast 2025-2030 ($ million)
- Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
- Chart on Argentina - Year-over-year growth 2025-2030 (%)
- Data Table on Argentina - Year-over-year growth 2025-2030 (%)
- Chart on Colombia - Market size and forecast 2025-2030 ($ million)
- Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
- Chart on Colombia - Year-over-year growth 2025-2030 (%)
- Data Table on Colombia - Year-over-year growth 2025-2030 (%)
- Chart on South Africa - Market size and forecast 2025-2030 ($ million)
- Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
- Chart on South Africa - Year-over-year growth 2025-2030 (%)
- Data Table on South Africa - Year-over-year growth 2025-2030 (%)
- Chart on Israel - Market size and forecast 2025-2030 ($ million)
- Data Table on Israel - Market size and forecast 2025-2030 ($ million)
- Chart on Israel - Year-over-year growth 2025-2030 (%)
- Data Table on Israel - Year-over-year growth 2025-2030 (%)
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
13.1 Market drivers
- Increasing prevalence of chronic and degenerative diseases
- Technological advancements and innovations in cell engineering
- Expanding clinical pipeline and strategic industry collaborations
- Prohibitive costs and complex reimbursement frameworks
- Intricate distribution and supply chain logistics
- Evolving and divergent regulatory landscapes
- Impact of drivers and challenges in 2025 and 2030
- Growing emphasis on allogenic and off-shelf therapies
- Strategic pivot towards solid tumor applications
- Integration of automation and digital technologies in manufacturing
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- Overview on factors of disruption
- Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
- Companies covered
- Company ranking index
- Matrix on companies position and classification
- AbelZeta Pharma Inc. - Overview
- AbelZeta Pharma Inc. - Product / Service
- AbelZeta Pharma Inc. - Key offerings
- SWOT
- Astellas Pharma Inc. - Overview
- Astellas Pharma Inc. - Product / Service
- Astellas Pharma Inc. - Key news
- Astellas Pharma Inc. - Key offerings
- SWOT
- Avita Medical Inc. - Overview
- Avita Medical Inc. - Product / Service
- Avita Medical Inc. - Key offerings
- SWOT
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key offerings
- Bayer AG - Segment focus
- SWOT
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product / Service
- Bristol Myers Squibb Co. - Key news
- Bristol Myers Squibb Co. - Key offerings
- SWOT
- Castle Creek Biosciences Inc. - Overview
- Castle Creek Biosciences Inc. - Product / Service
- Castle Creek Biosciences Inc. - Key offerings
- SWOT
- Celyad Oncology SA - Overview
- Celyad Oncology SA - Product / Service
- Celyad Oncology SA - Key offerings
- SWOT
- Gilead Sciences Inc. - Overview
- Gilead Sciences Inc. - Business segments
- Gilead Sciences Inc. - Key offerings
- Gilead Sciences Inc. - Segment focus
- SWOT
- Johnson and Johnson Services - Overview
- Johnson and Johnson Services - Business segments
- Johnson and Johnson Services - Key news
- Johnson and Johnson Services - Key offerings
- Johnson and Johnson Services - Segment focus
- SWOT
- Kite Pharma Inc. - Overview
- Kite Pharma Inc. - Product / Service
- Kite Pharma Inc. - Key offerings
- SWOT
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
- Sanpower Group Co. Ltd. - Overview
- Sanpower Group Co. Ltd. - Product / Service
- Sanpower Group Co. Ltd. - Key offerings
- SWOT
- Sarepta Therapeutics Inc. - Overview
- Sarepta Therapeutics Inc. - Product / Service
- Sarepta Therapeutics Inc. - Key offerings
- SWOT
- Vericel Corp. - Overview
- Vericel Corp. - Product / Service
- Vericel Corp. - Key offerings
- SWOT
- Vertex Pharmaceuticals Inc. - Overview
- Vertex Pharmaceuticals Inc. - Product / Service
- Vertex Pharmaceuticals Inc. - Key offerings
- SWOT
16 Appendix
16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- Inclusions checklist
- Exclusions checklist
- Currency conversion rates for US$
- Research methodology
- Information sources
- Data validation
- Validation techniques employed for market sizing
- Data synthesis
- 360 degree market analysis
- List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Type
Exhibit 6: Executive Summary - Chart on Market Segmentation by Application
Exhibit 7: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Cell Therapy Market 2020 - 2024 ($ million)
Exhibit 26: Historic Market Size - Type Segment 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Application Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - End-user Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Type - Market share 2025-2030 (%)
Exhibit 39: Data Table on Type - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Type
Exhibit 41: Data Table on Comparison by Type
Exhibit 42: Chart on Autologous - Market size and forecast 2025-2030 ($ million)
Exhibit 43: Data Table on Autologous - Market size and forecast 2025-2030 ($ million)
Exhibit 44: Chart on Autologous - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on Autologous - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Allogenic - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Data Table on Allogenic - Market size and forecast 2025-2030 ($ million)
Exhibit 48: Chart on Allogenic - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Allogenic - Year-over-year growth 2025-2030 (%)
Exhibit 50: Market opportunity by Type ($ million)
Exhibit 51: Data Table on Market opportunity by Type ($ million)
Exhibit 52: Chart on Application - Market share 2025-2030 (%)
Exhibit 53: Data Table on Application - Market share 2025-2030 (%)
Exhibit 54: Chart on Comparison by Application
Exhibit 55: Data Table on Comparison by Application
Exhibit 56: Chart on Malignancies - Market size and forecast 2025-2030 ($ million)
Exhibit 57: Data Table on Malignancies - Market size and forecast 2025-2030 ($ million)
Exhibit 58: Chart on Malignancies - Year-over-year growth 2025-2030 (%)
Exhibit 59: Data Table on Malignancies - Year-over-year growth 2025-2030 (%)
Exhibit 60: Chart on Musculoskeletal - Market size and forecast 2025-2030 ($ million)
Exhibit 61: Data Table on Musculoskeletal - Market size and forecast 2025-2030 ($ million)
Exhibit 62: Chart on Musculoskeletal - Year-over-year growth 2025-2030 (%)
Exhibit 63: Data Table on Musculoskeletal - Year-over-year growth 2025-2030 (%)
Exhibit 64: Chart on Cardiovascular - Market size and forecast 2025-2030 ($ million)
Exhibit 65: Data Table on Cardiovascular - Market size and forecast 2025-2030 ($ million)
Exhibit 66: Chart on Cardiovascular - Year-over-year growth 2025-2030 (%)
Exhibit 67: Data Table on Cardiovascular - Year-over-year growth 2025-2030 (%)
Exhibit 68: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 69: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 70: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 71: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 72: Market opportunity by Application ($ million)
Exhibit 73: Data Table on Market opportunity by Application ($ million)
Exhibit 74: Chart on End-user - Market share 2025-2030 (%)
Exhibit 75: Data Table on End-user - Market share 2025-2030 (%)
Exhibit 76: Chart on Comparison by End-user
Exhibit 77: Data Table on Comparison by End-user
Exhibit 78: Chart on Biopharmaceutical companies - Market size and forecast 2025-2030 ($ million)
Exhibit 79: Data Table on Biopharmaceutical companies - Market size and forecast 2025-2030 ($ million)
Exhibit 80: Chart on Biopharmaceutical companies - Year-over-year growth 2025-2030 (%)
Exhibit 81: Data Table on Biopharmaceutical companies - Year-over-year growth 2025-2030 (%)
Exhibit 82: Chart on CMOs - Market size and forecast 2025-2030 ($ million)
Exhibit 83: Data Table on CMOs - Market size and forecast 2025-2030 ($ million)
Exhibit 84: Chart on CMOs - Year-over-year growth 2025-2030 (%)
Exhibit 85: Data Table on CMOs - Year-over-year growth 2025-2030 (%)
Exhibit 86: Chart on CROs - Market size and forecast 2025-2030 ($ million)
Exhibit 87: Data Table on CROs - Market size and forecast 2025-2030 ($ million)
Exhibit 88: Chart on CROs - Year-over-year growth 2025-2030 (%)
Exhibit 89: Data Table on CROs - Year-over-year growth 2025-2030 (%)
Exhibit 90: Chart on Academic and research institutes - Market size and forecast 2025-2030 ($ million)
Exhibit 91: Data Table on Academic and research institutes - Market size and forecast 2025-2030 ($ million)
Exhibit 92: Chart on Academic and research institutes - Year-over-year growth 2025-2030 (%)
Exhibit 93: Data Table on Academic and research institutes - Year-over-year growth 2025-2030 (%)
Exhibit 94: Market opportunity by End-user ($ million)
Exhibit 95: Data Table on Market opportunity by End-user ($ million)
Exhibit 96: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 97: Chart on Market share by geography 2025-2030 (%)
Exhibit 98: Data Table on Market share by geography 2025-2030 (%)
Exhibit 99: Chart on Geographic comparison
Exhibit 100: Data Table on Geographic comparison
Exhibit 101: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 102: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 103: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 104: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 105: Chart on Regional Comparison - North America
Exhibit 106: Data Table on Regional Comparison - North America
Exhibit 107: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 108: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 109: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 110: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 111: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 112: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 113: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 114: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 115: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 116: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 117: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 118: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 119: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 120: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 121: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 122: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 123: Chart on Regional Comparison - Europe
Exhibit 124: Data Table on Regional Comparison - Europe
Exhibit 125: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 126: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 127: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 128: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 129: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 130: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 131: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 134: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 135: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 143: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 146: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 147: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 148: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 149: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 150: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 151: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 152: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 153: Chart on Regional Comparison - Asia
Exhibit 154: Data Table on Regional Comparison - Asia
Exhibit 155: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 156: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 157: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 158: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 159: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 160: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 161: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 162: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 163: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 164: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 165: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 166: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 167: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 168: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 169: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 173: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 176: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 177: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 178: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 179: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 180: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 181: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 182: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 183: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 184: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 185: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 186: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 187: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 188: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 189: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 190: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 191: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 192: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 193: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 194: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 195: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 196: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 197: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 198: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 199: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 201: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 202: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 203: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 205: Chart on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 206: Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 207: Chart on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 209: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 210: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 211: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 212: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 213: Chart on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 214: Data Table on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 215: Chart on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 216: Data Table on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 217: Market opportunity by geography ($ million)
Exhibit 218: Data Tables on Market opportunity by geography ($ million)
Exhibit 219: Impact of drivers and challenges in 2025 and 2030
Exhibit 220: Overview on criticality of inputs and factors of differentiation
Exhibit 221: Overview on factors of disruption
Exhibit 222: Impact of key risks on business
Exhibit 223: Companies covered
Exhibit 224: Company ranking index
Exhibit 225: Matrix on companies position and classification
Exhibit 226: AbelZeta Pharma Inc. - Overview
Exhibit 227: AbelZeta Pharma Inc. - Product / Service
Exhibit 228: AbelZeta Pharma Inc. - Key offerings
Exhibit 229: SWOT
Exhibit 230: Astellas Pharma Inc. - Overview
Exhibit 231: Astellas Pharma Inc. - Product / Service
Exhibit 232: Astellas Pharma Inc. - Key news
Exhibit 233: Astellas Pharma Inc. - Key offerings
Exhibit 234: SWOT
Exhibit 235: Avita Medical Inc. - Overview
Exhibit 236: Avita Medical Inc. - Product / Service
Exhibit 237: Avita Medical Inc. - Key offerings
Exhibit 238: SWOT
Exhibit 239: Bayer AG - Overview
Exhibit 240: Bayer AG - Business segments
Exhibit 241: Bayer AG - Key offerings
Exhibit 242: Bayer AG - Segment focus
Exhibit 243: SWOT
Exhibit 244: Bristol Myers Squibb Co. - Overview
Exhibit 245: Bristol Myers Squibb Co. - Product / Service
Exhibit 246: Bristol Myers Squibb Co. - Key news
Exhibit 247: Bristol Myers Squibb Co. - Key offerings
Exhibit 248: SWOT
Exhibit 249: Castle Creek Biosciences Inc. - Overview
Exhibit 250: Castle Creek Biosciences Inc. - Product / Service
Exhibit 251: Castle Creek Biosciences Inc. - Key offerings
Exhibit 252: SWOT
Exhibit 253: Celyad Oncology SA - Overview
Exhibit 254: Celyad Oncology SA - Product / Service
Exhibit 255: Celyad Oncology SA - Key offerings
Exhibit 256: SWOT
Exhibit 257: Gilead Sciences Inc. - Overview
Exhibit 258: Gilead Sciences Inc. - Business segments
Exhibit 259: Gilead Sciences Inc. - Key offerings
Exhibit 260: Gilead Sciences Inc. - Segment focus
Exhibit 261: SWOT
Exhibit 262: Johnson and Johnson Services - Overview
Exhibit 263: Johnson and Johnson Services - Business segments
Exhibit 264: Johnson and Johnson Services - Key news
Exhibit 265: Johnson and Johnson Services - Key offerings
Exhibit 266: Johnson and Johnson Services - Segment focus
Exhibit 267: SWOT
Exhibit 268: Kite Pharma Inc. - Overview
Exhibit 269: Kite Pharma Inc. - Product / Service
Exhibit 270: Kite Pharma Inc. - Key offerings
Exhibit 271: SWOT
Exhibit 272: Novartis AG - Overview
Exhibit 273: Novartis AG - Business segments
Exhibit 274: Novartis AG - Key news
Exhibit 275: Novartis AG - Key offerings
Exhibit 276: Novartis AG - Segment focus
Exhibit 277: SWOT
Exhibit 278: Sanpower Group Co. Ltd. - Overview
Exhibit 279: Sanpower Group Co. Ltd. - Product / Service
Exhibit 280: Sanpower Group Co. Ltd. - Key offerings
Exhibit 281: SWOT
Exhibit 282: Sarepta Therapeutics Inc. - Overview
Exhibit 283: Sarepta Therapeutics Inc. - Product / Service
Exhibit 284: Sarepta Therapeutics Inc. - Key offerings
Exhibit 285: SWOT
Exhibit 286: Vericel Corp. - Overview
Exhibit 287: Vericel Corp. - Product / Service
Exhibit 288: Vericel Corp. - Key offerings
Exhibit 289: SWOT
Exhibit 290: Vertex Pharmaceuticals Inc. - Overview
Exhibit 291: Vertex Pharmaceuticals Inc. - Product / Service
Exhibit 292: Vertex Pharmaceuticals Inc. - Key offerings
Exhibit 293: SWOT
Exhibit 294: Inclusions checklist
Exhibit 295: Exclusions checklist
Exhibit 296: Currency conversion rates for US$
Exhibit 297: Research methodology
Exhibit 298: Information sources
Exhibit 299: Data validation
Exhibit 300: Validation techniques employed for market sizing
Exhibit 301: Data synthesis
Exhibit 302: 360 degree market analysis
Exhibit 303: List of abbreviations
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Type
Exhibit 6: Executive Summary - Chart on Market Segmentation by Application
Exhibit 7: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Cell Therapy Market 2020 - 2024 ($ million)
Exhibit 26: Historic Market Size - Type Segment 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Application Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - End-user Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Type - Market share 2025-2030 (%)
Exhibit 39: Data Table on Type - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Type
Exhibit 41: Data Table on Comparison by Type
Exhibit 42: Chart on Autologous - Market size and forecast 2025-2030 ($ million)
Exhibit 43: Data Table on Autologous - Market size and forecast 2025-2030 ($ million)
Exhibit 44: Chart on Autologous - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on Autologous - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Allogenic - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Data Table on Allogenic - Market size and forecast 2025-2030 ($ million)
Exhibit 48: Chart on Allogenic - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Allogenic - Year-over-year growth 2025-2030 (%)
Exhibit 50: Market opportunity by Type ($ million)
Exhibit 51: Data Table on Market opportunity by Type ($ million)
Exhibit 52: Chart on Application - Market share 2025-2030 (%)
Exhibit 53: Data Table on Application - Market share 2025-2030 (%)
Exhibit 54: Chart on Comparison by Application
Exhibit 55: Data Table on Comparison by Application
Exhibit 56: Chart on Malignancies - Market size and forecast 2025-2030 ($ million)
Exhibit 57: Data Table on Malignancies - Market size and forecast 2025-2030 ($ million)
Exhibit 58: Chart on Malignancies - Year-over-year growth 2025-2030 (%)
Exhibit 59: Data Table on Malignancies - Year-over-year growth 2025-2030 (%)
Exhibit 60: Chart on Musculoskeletal - Market size and forecast 2025-2030 ($ million)
Exhibit 61: Data Table on Musculoskeletal - Market size and forecast 2025-2030 ($ million)
Exhibit 62: Chart on Musculoskeletal - Year-over-year growth 2025-2030 (%)
Exhibit 63: Data Table on Musculoskeletal - Year-over-year growth 2025-2030 (%)
Exhibit 64: Chart on Cardiovascular - Market size and forecast 2025-2030 ($ million)
Exhibit 65: Data Table on Cardiovascular - Market size and forecast 2025-2030 ($ million)
Exhibit 66: Chart on Cardiovascular - Year-over-year growth 2025-2030 (%)
Exhibit 67: Data Table on Cardiovascular - Year-over-year growth 2025-2030 (%)
Exhibit 68: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 69: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 70: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 71: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 72: Market opportunity by Application ($ million)
Exhibit 73: Data Table on Market opportunity by Application ($ million)
Exhibit 74: Chart on End-user - Market share 2025-2030 (%)
Exhibit 75: Data Table on End-user - Market share 2025-2030 (%)
Exhibit 76: Chart on Comparison by End-user
Exhibit 77: Data Table on Comparison by End-user
Exhibit 78: Chart on Biopharmaceutical companies - Market size and forecast 2025-2030 ($ million)
Exhibit 79: Data Table on Biopharmaceutical companies - Market size and forecast 2025-2030 ($ million)
Exhibit 80: Chart on Biopharmaceutical companies - Year-over-year growth 2025-2030 (%)
Exhibit 81: Data Table on Biopharmaceutical companies - Year-over-year growth 2025-2030 (%)
Exhibit 82: Chart on CMOs - Market size and forecast 2025-2030 ($ million)
Exhibit 83: Data Table on CMOs - Market size and forecast 2025-2030 ($ million)
Exhibit 84: Chart on CMOs - Year-over-year growth 2025-2030 (%)
Exhibit 85: Data Table on CMOs - Year-over-year growth 2025-2030 (%)
Exhibit 86: Chart on CROs - Market size and forecast 2025-2030 ($ million)
Exhibit 87: Data Table on CROs - Market size and forecast 2025-2030 ($ million)
Exhibit 88: Chart on CROs - Year-over-year growth 2025-2030 (%)
Exhibit 89: Data Table on CROs - Year-over-year growth 2025-2030 (%)
Exhibit 90: Chart on Academic and research institutes - Market size and forecast 2025-2030 ($ million)
Exhibit 91: Data Table on Academic and research institutes - Market size and forecast 2025-2030 ($ million)
Exhibit 92: Chart on Academic and research institutes - Year-over-year growth 2025-2030 (%)
Exhibit 93: Data Table on Academic and research institutes - Year-over-year growth 2025-2030 (%)
Exhibit 94: Market opportunity by End-user ($ million)
Exhibit 95: Data Table on Market opportunity by End-user ($ million)
Exhibit 96: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 97: Chart on Market share by geography 2025-2030 (%)
Exhibit 98: Data Table on Market share by geography 2025-2030 (%)
Exhibit 99: Chart on Geographic comparison
Exhibit 100: Data Table on Geographic comparison
Exhibit 101: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 102: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 103: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 104: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 105: Chart on Regional Comparison - North America
Exhibit 106: Data Table on Regional Comparison - North America
Exhibit 107: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 108: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 109: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 110: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 111: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 112: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 113: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 114: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 115: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 116: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 117: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 118: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 119: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 120: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 121: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 122: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 123: Chart on Regional Comparison - Europe
Exhibit 124: Data Table on Regional Comparison - Europe
Exhibit 125: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 126: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 127: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 128: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 129: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 130: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 131: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 134: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 135: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 143: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 146: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 147: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 148: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 149: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 150: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 151: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 152: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 153: Chart on Regional Comparison - Asia
Exhibit 154: Data Table on Regional Comparison - Asia
Exhibit 155: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 156: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 157: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 158: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 159: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 160: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 161: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 162: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 163: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 164: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 165: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 166: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 167: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 168: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 169: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 173: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 176: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 177: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 178: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 179: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 180: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 181: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 182: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 183: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 184: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 185: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 186: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 187: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 188: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 189: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 190: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 191: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 192: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 193: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 194: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 195: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 196: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 197: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 198: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 199: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 201: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 202: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 203: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 205: Chart on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 206: Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 207: Chart on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 209: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 210: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 211: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 212: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 213: Chart on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 214: Data Table on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 215: Chart on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 216: Data Table on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 217: Market opportunity by geography ($ million)
Exhibit 218: Data Tables on Market opportunity by geography ($ million)
Exhibit 219: Impact of drivers and challenges in 2025 and 2030
Exhibit 220: Overview on criticality of inputs and factors of differentiation
Exhibit 221: Overview on factors of disruption
Exhibit 222: Impact of key risks on business
Exhibit 223: Companies covered
Exhibit 224: Company ranking index
Exhibit 225: Matrix on companies position and classification
Exhibit 226: AbelZeta Pharma Inc. - Overview
Exhibit 227: AbelZeta Pharma Inc. - Product / Service
Exhibit 228: AbelZeta Pharma Inc. - Key offerings
Exhibit 229: SWOT
Exhibit 230: Astellas Pharma Inc. - Overview
Exhibit 231: Astellas Pharma Inc. - Product / Service
Exhibit 232: Astellas Pharma Inc. - Key news
Exhibit 233: Astellas Pharma Inc. - Key offerings
Exhibit 234: SWOT
Exhibit 235: Avita Medical Inc. - Overview
Exhibit 236: Avita Medical Inc. - Product / Service
Exhibit 237: Avita Medical Inc. - Key offerings
Exhibit 238: SWOT
Exhibit 239: Bayer AG - Overview
Exhibit 240: Bayer AG - Business segments
Exhibit 241: Bayer AG - Key offerings
Exhibit 242: Bayer AG - Segment focus
Exhibit 243: SWOT
Exhibit 244: Bristol Myers Squibb Co. - Overview
Exhibit 245: Bristol Myers Squibb Co. - Product / Service
Exhibit 246: Bristol Myers Squibb Co. - Key news
Exhibit 247: Bristol Myers Squibb Co. - Key offerings
Exhibit 248: SWOT
Exhibit 249: Castle Creek Biosciences Inc. - Overview
Exhibit 250: Castle Creek Biosciences Inc. - Product / Service
Exhibit 251: Castle Creek Biosciences Inc. - Key offerings
Exhibit 252: SWOT
Exhibit 253: Celyad Oncology SA - Overview
Exhibit 254: Celyad Oncology SA - Product / Service
Exhibit 255: Celyad Oncology SA - Key offerings
Exhibit 256: SWOT
Exhibit 257: Gilead Sciences Inc. - Overview
Exhibit 258: Gilead Sciences Inc. - Business segments
Exhibit 259: Gilead Sciences Inc. - Key offerings
Exhibit 260: Gilead Sciences Inc. - Segment focus
Exhibit 261: SWOT
Exhibit 262: Johnson and Johnson Services - Overview
Exhibit 263: Johnson and Johnson Services - Business segments
Exhibit 264: Johnson and Johnson Services - Key news
Exhibit 265: Johnson and Johnson Services - Key offerings
Exhibit 266: Johnson and Johnson Services - Segment focus
Exhibit 267: SWOT
Exhibit 268: Kite Pharma Inc. - Overview
Exhibit 269: Kite Pharma Inc. - Product / Service
Exhibit 270: Kite Pharma Inc. - Key offerings
Exhibit 271: SWOT
Exhibit 272: Novartis AG - Overview
Exhibit 273: Novartis AG - Business segments
Exhibit 274: Novartis AG - Key news
Exhibit 275: Novartis AG - Key offerings
Exhibit 276: Novartis AG - Segment focus
Exhibit 277: SWOT
Exhibit 278: Sanpower Group Co. Ltd. - Overview
Exhibit 279: Sanpower Group Co. Ltd. - Product / Service
Exhibit 280: Sanpower Group Co. Ltd. - Key offerings
Exhibit 281: SWOT
Exhibit 282: Sarepta Therapeutics Inc. - Overview
Exhibit 283: Sarepta Therapeutics Inc. - Product / Service
Exhibit 284: Sarepta Therapeutics Inc. - Key offerings
Exhibit 285: SWOT
Exhibit 286: Vericel Corp. - Overview
Exhibit 287: Vericel Corp. - Product / Service
Exhibit 288: Vericel Corp. - Key offerings
Exhibit 289: SWOT
Exhibit 290: Vertex Pharmaceuticals Inc. - Overview
Exhibit 291: Vertex Pharmaceuticals Inc. - Product / Service
Exhibit 292: Vertex Pharmaceuticals Inc. - Key offerings
Exhibit 293: SWOT
Exhibit 294: Inclusions checklist
Exhibit 295: Exclusions checklist
Exhibit 296: Currency conversion rates for US$
Exhibit 297: Research methodology
Exhibit 298: Information sources
Exhibit 299: Data validation
Exhibit 300: Validation techniques employed for market sizing
Exhibit 301: Data synthesis
Exhibit 302: 360 degree market analysis
Exhibit 303: List of abbreviations
Executive Summary
The following companies are recognized as the key players in the global global cell therapy market: AbelZeta Pharma Inc., Astellas Pharma Inc., Athersys Inc., Avita Medical Inc., Bayer AG, Bristol Myers Squibb Co., Castle Creek Biosciences Inc., Celyad Oncology SA, CRISPR Therapeutics AG, Gilead Sciences Inc., Johnson and Johnson Services, Kite Pharma Inc., Lineage Cell Therapeutics Inc., Novartis AG, Pharmicell Co. Ltd., Sanpower Group Co. Ltd., Sarepta Therapeutics Inc., Vericel Corp., Vertex Pharmaceuticals Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is growing emphasis on allogenic and off-shelf therapies."
According to the report, one of the major drivers for this market is the increasing prevalence of chronic and degenerative diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbelZeta Pharma Inc.
- Astellas Pharma Inc.
- Athersys Inc.
- Avita Medical Inc.
- Bayer AG
- Bristol Myers Squibb Co.
- Castle Creek Biosciences Inc.
- Celyad Oncology SA
- CRISPR Therapeutics AG
- Gilead Sciences Inc.
- Johnson and Johnson Services
- Kite Pharma Inc.
- Lineage Cell Therapeutics Inc.
- Novartis AG
- Pharmicell Co. Ltd.
- Sanpower Group Co. Ltd.
- Sarepta Therapeutics Inc.
- Vericel Corp.
- Vertex Pharmaceuticals Inc.
